ID   HA33C_CBCP              Reviewed;         286 AA.
AC   P0DPR0; P46084; Q9LBR3; Q9LBS9; Q9ZWV4;
DT   07-NOV-2018, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2018, sequence version 1.
DT   25-MAY-2022, entry version 14.
DE   RecName: Full=Main hemagglutinin component type C {ECO:0000303|PubMed:2205574};
DE   AltName: Full=ANTP33 {ECO:0000303|PubMed:7570637};
DE   AltName: Full=HA 33 kDa subunit {ECO:0000303|PubMed:2205574};
DE   AltName: Full=HA1;
GN   Name=HA-33 {ECO:0000303|PubMed:2205574};
GN   Synonyms=antP-33 {ECO:0000303|PubMed:7570637}, ha1;
OS   Clostridium botulinum C phage (Clostridium botulinum C bacteriophage).
OC   Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Caudoviricetes;
OC   Caudovirales; Siphoviridae.
OX   NCBI_TaxID=12336;
OH   NCBI_TaxID=36828; Clostridium botulinum C.
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-21, FUNCTION IN
RP   AGGLUTINATION OF ERYTHROCYTES, AND SUBCELLULAR LOCATION.
RC   STRAIN=Stockholm / Type C / phage C-ST;
RX   PubMed=2205574; DOI=10.1128/iai.58.10.3173-3177.1990;
RA   Tsuzuki K., Kimura K., Fujii N., Yokosawa N., Indoh T., Murakami T.,
RA   Oguma K.;
RT   "Cloning and complete nucleotide sequence of the gene for the main
RT   component of hemagglutinin produced by Clostridium botulinum type C.";
RL   Infect. Immun. 58:3173-3177(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=C-468 / Type C;
RX   PubMed=7570637; DOI=10.1016/0041-0101(94)00190-j;
RA   Hauser D., Gibert M., Marvaud J.C., Eklund M.W., Popoff M.R.;
RT   "Botulinal neurotoxin C1 complex genes, clostridial neurotoxin homology and
RT   genetic transfer in Clostridium botulinum.";
RL   Toxicon 33:515-526(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=C-6814 / Type C;
RA   Sagane Y., Watanabe T., Kouguchi H., Yamamoto T., Kawabe T., Murakami F.,
RA   Nakatsuka M., Ohyama T.;
RT   "Organization of gene encoding components of the botulinum progenitor toxin
RT   in Clostridium botulinum type C strain 6814: evidence of chimeric sequence
RT   in the gene encoding each component.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 269-286, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RC   STRAIN=Stockholm / Type C / phage C-ST;
RX   PubMed=7802661; DOI=10.1006/bbrc.1994.2805;
RA   Fujinaga Y., Inoue K., Shimazaki S., Tomochika K., Tsuzuki K., Fujii N.,
RA   Watanabe T., Ohyama T., Takeshi K., Inoue K., Oguma K.;
RT   "Molecular construction of Clostridium botulinum type C progenitor toxin
RT   and its gene organization.";
RL   Biochem. Biophys. Res. Commun. 205:1291-1298(1994).
RN   [5]
RP   FUNCTION IN TOXICITY.
RC   STRAIN=Stockholm / Type C;
RX   PubMed=9421908; DOI=10.1099/00221287-143-12-3841;
RA   Fujinaga Y., Inoue K., Watanabe S., Yokota K., Hirai Y., Nagamachi E.,
RA   Oguma K.;
RT   "The haemagglutinin of Clostridium botulinum type C progenitor toxin plays
RT   an essential role in binding of toxin to the epithelial cells of guinea pig
RT   small intestine, leading to the efficient absorption of the toxin.";
RL   Microbiology 143:3841-3847(1997).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS), FUNCTION IN SUGAR-BINDING, AND
RP   DOMAIN.
RC   STRAIN=Stockholm / Type C;
RX   PubMed=14663070; DOI=10.1099/mic.0.26586-0;
RA   Inoue K., Sobhany M., Transue T.R., Oguma K., Pedersen L.C., Negishi M.;
RT   "Structural analysis by X-ray crystallography and calorimetry of a
RT   haemagglutinin component (HA1) of the progenitor toxin from Clostridium
RT   botulinum.";
RL   Microbiology 149:3361-3370(2003).
RN   [7] {ECO:0007744|PDB:3AH1, ECO:0007744|PDB:3AH2, ECO:0007744|PDB:3AH4}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH GALACTOSE;
RP   N-ACETYL-BETA-NEURAMIC ACID AND N-ACETYL-D-GALACTOSAMINE, FUNCTION IN
RP   MUCIN-BINDING, SUGAR-BINDING, DOMAIN, AND MUTAGENESIS OF TRP-176.
RX   PubMed=18178224; DOI=10.1016/j.jmb.2007.12.031;
RA   Nakamura T., Tonozuka T., Ide A., Yuzawa T., Oguma K., Nishikawa A.;
RT   "Sugar-binding sites of the HA1 subcomponent of Clostridium botulinum type
RT   C progenitor toxin.";
RL   J. Mol. Biol. 376:854-867(2008).
RN   [8] {ECO:0007744|PDB:3AJ5, ECO:0007744|PDB:3AJ6}
RP   X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS) IN COMPLEX WITH
RP   N-ACETYL-D-GALACTOSAMINE, FUNCTION IN MUCIN-BINDING, SUGAR-BINDING, DOMAIN,
RP   AND MUTAGENESIS OF TRP-176; PHE-179; ASP-271 AND 278-ASN-GLN-279.
RX   PubMed=21640703; DOI=10.1016/j.abb.2011.05.012;
RA   Nakamura T., Tonozuka T., Ito S., Takeda Y., Sato R., Matsuo I., Ito Y.,
RA   Oguma K., Nishikawa A.;
RT   "Molecular diversity of the two sugar-binding sites of the beta-trefoil
RT   lectin HA33/C (HA1) from Clostridium botulinum type C neurotoxin.";
RL   Arch. Biochem. Biophys. 512:69-77(2011).
CC   -!- FUNCTION: Agglutinates human erythrocytes (PubMed:2205574). The
CC       hemagglutinin (HA) component of the progenitor toxin protects the
CC       structural integrity of botulinum neurotoxin; may increase
CC       internalization of the neurotoxin into the bloodstream of the host
CC       (PubMed:9421908). The hemagglutinin (HA) component is involved in
CC       binding to the upper small intestine through interactions with
CC       glycolipids and glycoproteins containing sialic acid moieties
CC       (Probable). Binds galactose or oligosaccharides with galactose at their
CC       non-reducing end (PubMed:14663070). Binds eukaryotic host mucins;
CC       binding is inhibited by N-acetyl-beta-neuraminic acid, N-acetyl-D-
CC       galactosamine, galactose, and methyl N-acetyl-beta-neuraminic acid
CC       (PubMed:18178224). Binds N-acetyl-beta-neuraminic acid, N-acetyl-D-
CC       galactosamine and galactose (but not glucose) via 2 sites
CC       (PubMed:18178224, PubMed:21640703). {ECO:0000269|PubMed:14663070,
CC       ECO:0000269|PubMed:18178224, ECO:0000269|PubMed:21640703,
CC       ECO:0000269|PubMed:2205574, ECO:0000269|PubMed:9421908,
CC       ECO:0000305|PubMed:9421908}.
CC   -!- SUBUNIT: Botulinum toxins are produced as progenitor toxins of large
CC       molecular sizes of 12S (M toxin) and 16S (L toxin). M toxin consists of
CC       a non-toxic, non-hemagglutinin component (NTNHA) and the neurotoxin
CC       (Probable). L toxin consists of the M toxin and the 3 subcomponents of
CC       hemagglutinin (HA) (PubMed:7802661). HA is composed of subcomponents of
CC       70, 33, and 17 kDa (PubMed:7802661). The 70 kDa subcomponent undergoes
CC       proteolytic processing and is split into HA-55 (also called HA-53 and
CC       HA3b) and HA-22-23 (also called HA3a) (PubMed:7802661). The
CC       stoichiometry of the whole complex has been modeled as one BoNT/C, one
CC       NTNHA, three HA-70, six HA-33 and three HA-17 (By similarity).
CC       {ECO:0000250|UniProtKB:P0DPR1, ECO:0000269|PubMed:7802661,
CC       ECO:0000305|PubMed:7802661}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:2205574,
CC       ECO:0000269|PubMed:7802661}.
CC   -!- DOMAIN: Arranged in 2 beta-trefoil domains (called 1 and 2) each with
CC       three tandemly repeated subdomains (called alpha, beta and gamma)
CC       joined by a short alpha-helix (Probable). Only subdomains 2-alpha and
CC       2-gamma, in the C-terminal beta-trefoil domain, possess a functional
CC       carbohydrate-binding site (PubMed:18178224, PubMed:21640703).
CC       {ECO:0000269|PubMed:18178224, ECO:0000269|PubMed:21640703,
CC       ECO:0000305|PubMed:14663070, ECO:0000305|PubMed:18178224,
CC       ECO:0000305|PubMed:21640703}.
CC   -!- MISCELLANEOUS: This protein can also be encoded on a prophage.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62389; CAA44261.1; -; Genomic_DNA.
DR   EMBL; X53041; CAA37210.1; -; Genomic_DNA.
DR   EMBL; X66433; CAA47058.1; -; Genomic_DNA.
DR   EMBL; AB037166; BAA89711.1; -; Genomic_DNA.
DR   EMBL; S74768; AAB32847.1; -; Genomic_DNA.
DR   RefSeq; YP_398514.1; NC_007581.1.
DR   PDB; 1QXM; X-ray; 1.70 A; A/B=1-286.
DR   PDB; 3AH1; X-ray; 2.20 A; A/B=1-286.
DR   PDB; 3AH2; X-ray; 1.70 A; A/B=1-286.
DR   PDB; 3AH4; X-ray; 1.78 A; A/B=1-286.
DR   PDB; 3AJ5; X-ray; 1.80 A; A/B=1-286.
DR   PDB; 3AJ6; X-ray; 1.48 A; A/B=1-286.
DR   PDBsum; 1QXM; -.
DR   PDBsum; 3AH1; -.
DR   PDBsum; 3AH2; -.
DR   PDBsum; 3AH4; -.
DR   PDBsum; 3AJ5; -.
DR   PDBsum; 3AJ6; -.
DR   SMR; P0DPR0; -.
DR   UniLectin; P0DPR0; -.
DR   GeneID; 3772939; -.
DR   KEGG; vg:3772939; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   CDD; cd00161; RICIN; 2.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   SMART; SM00458; RICIN; 2.
DR   SUPFAM; SSF50370; SSF50370; 2.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Hemagglutinin; Lectin; Repeat;
KW   Secreted; Virulence.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2205574"
FT   CHAIN           2..286
FT                   /note="Main hemagglutinin component type C"
FT                   /id="PRO_0000083886"
FT   REPEAT          2..55
FT                   /note="1-alpha"
FT                   /evidence="ECO:0000305|PubMed:14663070"
FT   DOMAIN          12..140
FT                   /note="Ricin B-type lectin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REPEAT          56..100
FT                   /note="1-beta"
FT                   /evidence="ECO:0000305|PubMed:14663070"
FT   REPEAT          101..148
FT                   /note="1-gamma"
FT                   /evidence="ECO:0000305|PubMed:14663070"
FT   REPEAT          149..193
FT                   /note="2-alpha"
FT                   /evidence="ECO:0000305|PubMed:14663070,
FT                   ECO:0000305|PubMed:18178224, ECO:0000305|PubMed:21640703"
FT   DOMAIN          180..284
FT                   /note="Ricin B-type lectin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REPEAT          194..239
FT                   /note="2-beta"
FT                   /evidence="ECO:0000305|PubMed:14663070,
FT                   ECO:0000305|PubMed:18178224, ECO:0000305|PubMed:21640703"
FT   REPEAT          240..286
FT                   /note="2-gamma"
FT                   /evidence="ECO:0000305|PubMed:14663070,
FT                   ECO:0000305|PubMed:18178224, ECO:0000305|PubMed:21640703"
FT   REGION          167..183
FT                   /note="Sugar-binding site 1"
FT                   /evidence="ECO:0000269|PubMed:18178224"
FT   REGION          256..279
FT                   /note="Sugar-binding site 2"
FT                   /evidence="ECO:0000269|PubMed:18178224,
FT                   ECO:0000269|PubMed:21640703"
FT   VARIANT         22
FT                   /note="N -> S (in strain: Type C / C-6814)"
FT   VARIANT         39..44
FT                   /note="NKLSGA -> SKNLGS (in strain: Type C / C-6814)"
FT   VARIANT         74
FT                   /note="N -> D (in strain: Type C / C-6814)"
FT   VARIANT         88..89
FT                   /note="GD -> TN (in strain: Type C / C-6814)"
FT   VARIANT         98
FT                   /note="N -> D (in strain: Type C / C-6814)"
FT   VARIANT         106
FT                   /note="I -> L (in strain: Type C / C-6814)"
FT   VARIANT         120
FT                   /note="I -> T (in strain: Type C / C-6814)"
FT   VARIANT         125
FT                   /note="M -> I (in strain: Type C / C-6814)"
FT   VARIANT         133
FT                   /note="S -> N (in strain: Type C / C-6814)"
FT   VARIANT         267
FT                   /note="H -> N (in strain: Type C / C-6814)"
FT   MUTAGEN         176
FT                   /note="W->A: Significantly decreased binding to bovine
FT                   mucin, decreased binding to porcine mucin. No binding of
FT                   N-acetyl-beta-neuraminic acid, significantly decreased
FT                   binding to N-acetyl-D-galactosamine. Significantly
FT                   decreased binding to both bovine and porcine mucin; when
FT                   associated with A-278-279-A."
FT                   /evidence="ECO:0000269|PubMed:18178224,
FT                   ECO:0000269|PubMed:21640703"
FT   MUTAGEN         179
FT                   /note="F->I: Decreased binding to bovine mucin, no change
FT                   in binding to porcine mucin. No binding of
FT                   N-acetyl-beta-neuraminic acid, significantly decreased
FT                   binding to N-acetyl-D-galactosamine."
FT                   /evidence="ECO:0000269|PubMed:21640703"
FT   MUTAGEN         271
FT                   /note="D->F: No binding of N-acetyl-beta-neuraminic acid,
FT                   increased binding to N-acetyl-D-galactosamine and
FT                   galactose; when associated with A-176."
FT                   /evidence="ECO:0000269|PubMed:21640703"
FT   MUTAGEN         278..279
FT                   /note="NQ->AA: Decreased binding to both bovine and porcine
FT                   mucin, no binding to N-acetyl-D-galactosamine, increased
FT                   affinity for N-acetyl-beta-neuraminic acid. Significantly
FT                   decreased binding to both bovine and porcine mucin; when
FT                   associated with A-176."
FT                   /evidence="ECO:0000269|PubMed:21640703"
FT   STRAND          14..19
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          25..29
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          31..33
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          35..39
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           44..46
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          48..53
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   TURN            54..57
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          58..67
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          70..73
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          80..83
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           89..91
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          93..97
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   TURN            99..101
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          104..110
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          114..118
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          124..128
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          137..141
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           142..147
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          150..156
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          163..166
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          170..176
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           182..184
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          186..191
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   TURN            192..195
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          196..201
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   TURN            202..204
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          207..210
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          213..215
FT                   /evidence="ECO:0007829|PDB:3AH1"
FT   STRAND          217..221
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           227..229
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          231..236
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          239..247
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          250..257
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           258..260
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          267..272
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   HELIX           277..279
FT                   /evidence="ECO:0007829|PDB:3AJ6"
FT   STRAND          281..285
FT                   /evidence="ECO:0007829|PDB:3AJ6"
SQ   SEQUENCE   286 AA;  33753 MW;  221C2500C8B187EA CRC64;
     MSQTNANDLR NNEVFFISPS NNTNKVLDKI SQSEVKLWNK LSGANQKWRL IYDTNKQAYK
     IKVMDNTSLI LTWNAPLSSV SVKTDTNGDN QYWYLLQNYI SRNVIIRNYM NPNLVLQYNI
     DDTLMVSTQT SSSNQFFKFS NCIYEALNNR NCKLQTQLNS DRFLSKNLNS QIIVLWQWFD
     SSRQKWIIEY NETKSAYTLK CQENNRYLTW IQNSNNYVET YQSTDSLIQY WNINYLDNDA
     SKYILYNLQD TNRVLDVYNS QIANGTHVIV DSYHGNTNQQ WIINLI
//
